Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-5.8%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
-$10.3M
Cap. Flow %
-0.07%
Top 10 Hldgs %
34.96%
Holding
1,378
New
24
Increased
673
Reduced
253
Closed
31

Sector Composition

1 Real Estate 53.26%
2 Technology 12.67%
3 Healthcare 4.75%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TBPH icon
1201
Theravance Biopharma
TBPH
$703M
$2K ﹤0.01%
215
TVTX icon
1202
Travere Therapeutics
TVTX
$1.93B
$2K ﹤0.01%
258
WVE icon
1203
Wave Life Sciences
WVE
$1.32B
$2K ﹤0.01%
349
PETQ
1204
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
PGEN icon
1205
Precigen
PGEN
$1.3B
$1K ﹤0.01%
708
ABOS icon
1206
Acumen Pharmaceuticals
ABOS
$87.2M
$1K ﹤0.01%
165
ABUS icon
1207
Arbutus Biopharma
ABUS
$805M
$1K ﹤0.01%
395
ALLK
1208
DELISTED
Allakos
ALLK
$1K ﹤0.01%
343
ALXO icon
1209
ALX Oncology
ALXO
$65.3M
$1K ﹤0.01%
138
AMRN
1210
Amarin Corp
AMRN
$317M
$1K ﹤0.01%
67
ARQT icon
1211
Arcutis Biotherapeutics
ARQT
$2.06B
$1K ﹤0.01%
245
AVIR icon
1212
Atea Pharmaceuticals
AVIR
$267M
$1K ﹤0.01%
242
BATRK icon
1213
Atlanta Braves Holdings Series B
BATRK
$2.66B
$1K ﹤0.01%
+28
New +$1K
BMEA icon
1214
Biomea Fusion
BMEA
$114M
$1K ﹤0.01%
109
CGEM icon
1215
Cullinan Oncology
CGEM
$413M
$1K ﹤0.01%
127
CHRS icon
1216
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$1K ﹤0.01%
262
CNTA
1217
Centessa Pharmaceuticals
CNTA
$2.11B
$1K ﹤0.01%
211
CRBU icon
1218
Caribou Biosciences
CRBU
$174M
$1K ﹤0.01%
176
CSTL icon
1219
Castle Biosciences
CSTL
$683M
$1K ﹤0.01%
86
ENTA icon
1220
Enanta Pharmaceuticals
ENTA
$189M
$1K ﹤0.01%
69
EOLS icon
1221
Evolus
EOLS
$495M
$1K ﹤0.01%
162
ERAS icon
1222
Erasca
ERAS
$457M
$1K ﹤0.01%
354
EWTX icon
1223
Edgewise Therapeutics
EWTX
$1.64B
$1K ﹤0.01%
254
FATE icon
1224
Fate Therapeutics
FATE
$116M
$1K ﹤0.01%
360
FHTX icon
1225
Foghorn Therapeutics
FHTX
$326M
$1K ﹤0.01%
168